Exicure, Inc. Reports Full Year 2023 Financial Results : vim

Exicure, Inc. has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, the Company announced a significant reduction in force,...

Related Keywords

, Company Annual Report On Form , Exicure Inc , Nasdaq , Development Rd Expense , Co Ltd , Reports Full Year , Private Securities Litigation Reform Act , Annual Report ,